๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Histone Deacetylase Inhibitors: Development of Suberoylanilide Hydroxamic Acid (SAHA) for the Treatment of Cancers

โœ Scribed by Victoria M. Richon; Xianbo Zhou; Richard A. Rifkind; Paul A. Marks


Book ID
115590107
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
39 KB
Volume
27
Category
Article
ISSN
1079-9796

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Histone deacetylase inhibitor, suberoyla
โœ Takashi Kumagai; Naoki Wakimoto; Dong Yin; Sigal Gery; Norihiko Kawamata; Noriyu ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 461 KB ๐Ÿ‘ 1 views

## Abstract Tumor suppressor genes are often silenced in human cancer; this can occur by transcriptional repression by deacetylation in the promoter regions, mediated by histone deacetylase (HDAC). HDAC inhibitors can block cancer cell growth by restoring expression of tumor suppressor genes. In th

Sequence-specific potentiation of topois
โœ Douglas C. Marchion; Elona Bicaku; Adil I. Daud; Victoria Richon; Daniel M. Sull ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 469 KB ๐Ÿ‘ 1 views

## Abstract Acetylation of histones leads to conformational changes of DNA. We have previously shown that the histone deacetylase (HDAC) inhibitor, suberoylanilide hydroxamic acid (SAHA), induced cell cycle arrest, differentiation, and apoptosis. In addition to their antitumor effects as single age